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Abstract
Background: Full-field digital mammography (FFDM) has largely replaced film-screen mammography in the US.
Breast density assessed from film mammograms is strongly associated with breast cancer risk, but data are limited
for processed FFDM images used for clinical care.
Methods: We conducted a case-control study nested among non-Hispanic white female participants of the
Research Program in Genes, Environment and Health of Kaiser Permanente Northern California who were aged 40
to 74 years and had screening mammograms acquired on Hologic FFDM machines. Cases (n = 297) were women
with a first invasive breast cancer diagnosed after a screening FFDM. For each case, up to five controls (n = 1149)
were selected, matched on age and year of FFDM and image batch number, and who were still under follow-up
and without a history of breast cancer at the age of diagnosis of the matched case. Percent density (PD) and dense
area (DA) were assessed by a radiological technologist using Cumulus. Conditional logistic regression was used to
estimate odds ratios (ORs) for breast cancer associated with PD and DA, modeled continuously in standard
deviation (SD) increments and categorically in quintiles, after adjusting for body mass index, parity, first-degree
family history of breast cancer, breast area, and menopausal hormone use.
Results: Median intra-reader reproducibility was high with a Pearson’s r of 0.956 (range 0.902 to 0.983) for replicate
PD measurements across 23 image batches. The overall mean was 20.02 (SD, 14.61) for PD and 27.63 cm2 (18.
22 cm2) for DA. The adjusted ORs for breast cancer associated with each SD increment were 1.70 (95 % confidence
interval, 1.41–2.04) for PD, and 1.54 (1.34–1.77) for DA. The adjusted ORs for each quintile were: 1.00 (ref.), 1.49
(0.91–2.45), 2.57 (1.54–4.30), 3.22 (1.91–5.43), 4.88 (2.78–8.55) for PD, and 1.00 (ref.), 1.43 (0.85–2.40), 2.53 (1.53–4.19),
2.85 (1.73–4.69), 3.48 (2.14–5.65) for DA.
Conclusions: PD and DA measured using Cumulus on processed FFDM images are positively associated with
breast cancer risk, with similar magnitudes of association as previously reported for film-screen mammograms.
Processed digital mammograms acquired for routine clinical care in a general practice setting are suitable for
breast density and cancer research.
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Background
A large body of epidemiologic research indicates that
mammographic density (the extent of the breast that
appears radiopaque on a mammogram) is strongly associ-
ated with breast cancer risk [1–3]. Most of this evidence
comes from studies that assessed breast density from
film-screen mammograms acquired after screening mam-
mography became widespread in the 1980s.
Over the last decade, conventional film mammography
has largely been replaced with full-field digital mammog-
raphy (FFDM). Both technologies use X-rays to produce
an image of the breast; one image is captured directly on
film, while the other is captured as digital data. In FFDM,
the raw images are processed for viewing and interpret-
ation by the breast imaging specialist. In addition to im-
proving the image aesthetics and visualization of breast
cancer, these processing algorithms, which differ by manu-
facturer, also reduce the size of the digital file [4]. The raw
digital images for mammography are some of the largest
diagnostic imaging files in clinical practice. Most mam-
mography facilities store only the processed FFDM images
for presentation and interpretation by the radiologist [5].
Only a few studies of the association of mammographic
density with breast cancer risk have been conducted using
FFDM images processed for clinical display [6, 7]. These
studies suggest that the association between breast density
assessed from FFDM images and breast cancer risk may
be slightly weaker than associations generally observed for
density assessed from film-screen mammograms. To
our knowledge, only one study has reported results for
processed images acquired using the Selenia Digital
Mammography System machines manufactured by Holo-
gic (Hologic, Inc., Marlborough, MA, USA) [7], which are
the most commonly used FFDM machines in the US. Since
the processing algorithms may change the appearance of
dense tissue on the digital mammogram, the objective of
this study was to determine whether percent density and
dense area of the breast, assessed from processed digital
images acquired from Hologic machines used in a general
clinical setting are associated with breast cancer risk.
Methods
Setting
This study is ancillary to a genome-wide association
study (GWAS) of mammographic density conducted
among approximately 27,000 non-Hispanic white female
participants of the Research Program in Genes, Environ-
ment and Health (RPGEH), who completed a health sur-
vey and provided a saliva sample for genotyping and
who had a least one screening FFDM between 2003 and
2013. The RPGEH was developed and is administered by
the Division of Research, Kaiser Permanente Northern
California (KPNC). Briefly, the RPGEH resource enables
research on the genetic and environmental determinants
of common, age-related complex health conditions. The
resource links together surveys, biospecimens, and de-
rived data, with longitudinal data from electronic health
records (EHRs) on a cohort of approximately 200,000
consenting adult KPNC members. Genome-wide geno-
typing has been performed on DNA extracted from sal-
iva samples of more than 100,000 RPGEH participants
enrolled before 2010 (RC2 AG036607).
Mammograms
The EHR was used to identify screening mammograms
on the study population. Processed FFDMs from 37 differ-
ent mammography facilities, with one to five machines
per facility, were obtained from the KPNC imaging arch-
ive. For women with a history of breast cancer, we ob-
tained the closest pre-diagnostic FFDM after the RPGEH
survey when available, or prior to the survey date other-
wise, and selected the craniocaudal (CC) view of the un-
affected breast (i.e., we used the left view for cases with
cancer in the right breast and the right view for cases with
cancer in the left breast). For control women, we ran-
domly selected the right CC view for approximately 10 %
to blind the reader to case-control status, and used the left
CC view otherwise. We excluded women with bilateral
breast cancer (n = 15), breast implants (n = 903), whose
breasts were too large to be completely imaged on a single
exposure (n = 245), or whose images were unreadable
(n = 44) or unavailable (n = 625). FFDM images, in Digital
Imaging and Communications in Medicine (DICOM)
format, were de-identified and downsampled from a pixel
size of 70 microns to a pixel size of 200 microns for
transfer to the Stanford Radiology 3D and Quantita-
tive Imaging Laboratory. Prior studies of scanned film
mammograms have used larger pixel size [8], which
would not be expected to influence computer-assisted
density measurements on standard monitors that have
lower resolution than the downsampled images.
Density assessments
FFDMs acquired from Selenia Digital Mammography
System machines manufactured by Hologic, Inc. for ap-
proximately 21,000 women were randomly assembled
into 23 batches of up to 1100 images including 10 %
random replicates for quality control. Density measure-
ments were estimated with the Cumulus interactive
threshold method [9]. We previously found that noise
reduction of processed Hologic FFDM images to make
them appear more film-like can significantly (p < 0.001)
improve the reproducibility of readers with little prior
experience applying Cumulus to processed FFDM im-
ages, and slightly increase the percent density measure-
ments by about two percentage points. As readers
gained experience over time, high levels of reproducibil-
ity (Pearson’s r >0.90) were attained on processed FFDM
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images with or without noise reduction. Here, we applied
a median filter with a radius of three pixels [10] to all
processed Hologic FFDM images (see Fig. 1 for a repre-
sentative image both before and after downsampling and
filtering). A single radiological technologist (RYL), trained
in Cumulus assessments by MJY and JAL and blinded to
case-control status, measured the total area of the breast
and area of dense tissue using Cumulus6 (provided by
MJY), which automatically detects the outer edge of the
breast for most digital mammograms. The Cumulus soft-
ware also calculated the percentage of the total breast area
occupied by dense tissue (percent density).
Cases and controls
This case-control study was nested among women be-
tween the ages of 40 and 74 years at Hologic FFDM.
Breast cancer diagnoses were identified from the KPNC
cancer registry, which reports to the California Cancer
Registry and to the National Cancer Institute’s Surveil-
lance, Epidemiology and End Results (SEER) program of
cancer registries. The KPNC registry records informa-
tion on all new primary cancers (except nonmelanoma
skin cancer) diagnosed among KPNC members. Data
elements and quality assurance measures are similar to
SEER. Cases (n = 297) were women with a first primary,
unilateral, invasive breast cancer diagnosed after a
FFDM. Up to five controls (n = 1149) were selected at
random from among women who matched the corre-
sponding case on age at FFDM (exact year), calendar
year at FFDM, breast laterality (left or right), and image
batch number, and who were still under follow-up and
without a history of breast cancer at the age of diagnosis
in the matched case.
Covariates
Age at mammogram was determined based on date of
birth (demographic database) and date of mammogram
(mammography database). We used the body mass index
(BMI) measured at the patient visit closest to mammo-
gram date when available from the EHR, and computed
from self-reported height and weight on the RPGEH sur-
vey otherwise. The RPGEH survey provided information
on parity and history of breast cancer in a first-degree
family member. The KPNC pharmacy database, which
records all dispensed outpatient and inpatient prescrip-
tions, was used to determine use of menopausal hor-
mones within the 2 years prior to FFDM.
Statistical methods
Conditional logistic regression was used to estimate
odds ratios (ORs) for breast cancer associated with per-
cent density (PD) and with dense area (DA). PD and DA
were categorized into quintiles based on their distribu-
tions in control women. We applied a square-root trans-
formation to PD and cube-root transformation to DA to
obtain normal distributions, and we modeled PD and
DA as continuous variables in units of the standard devi-
ation (SD) in controls. To maximize adjustment for BMI
(kg/m2), it was modeled as both a categorical variable
(<25, 25–29, 30–34, 35–39, 40+) and as a continuous
variable. Total breast area (cm2) was modeled as a con-
tinuous variable to facilitate comparison to previous
studies [6]. Parity was categorized as nulliparous, parous,
or missing. History of breast cancer in a first-degree
family member was categorized as yes or no. The use of
menopausal hormones was categorized as none, estrogen
alone, or estrogen plus progestin. To examine whether
Fig. 1 Representative full-field digital mammography image, with Cumulus dense tissue segmentation (outlined in green). On the left is the
original image before downsampling and median filtering; on the right is the image after downsampling (from pixel size of 70 microns to a pixel
size of 200 microns) and median filtering (with a radius of three pixels)
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associations between measures of density and breast cancer
risk varied by menopausal status, we conducted sub-
analyses restricted to women aged 50+ years as a surrogate
for postmenopausal status. The number of women younger
than 50 years of age was too small for meaningful results.
The study was approved by Institutional Review Boards
at Kaiser Permanente and Stanford University. All study
participants provided written informed consent.
Results
This study included 297 invasive breast cancer cases and
1149 matched controls (Table 1). Fewer than 5 % of
cases and controls were younger than 50 years of age at
reference date. Compared to controls, a smaller propor-
tion of cases had a BMI less than 25 and a slightly larger
proportion had a family history of breast cancer or were
nulliparous. Density measurements using Cumulus on
processed Hologic FFDM images were highly reprodu-
cible. The median intra-reader reproducibility, estimated
by Pearson’s r, was 0.956 (range 0.902 to 0.983) across 23
image batches read over a period of 7 months. The overall
mean was 20.02 (SD, 14.61) for PD and 27.63 cm2
(SD, 18.22 cm2) for DA.
Odds ratios (ORs) for the association between PD and
breast cancer risk are shown in Table 2. The results were
similar in models adjusted for BMI (model 1); BMI, par-
ity, first-degree family history, and menopausal hormone
use (model 2); or BMI, parity, first-degree family history,
menopausal hormone use, and breast area (model 3)
indicating little confounding by parity, first-degree
family history, hormone use, and breast area in our data.
Among all women, those in the highest quintile of PD had
a significantly increased risk of breast cancer (OR, 4.88;
95 % confidence interval (CI), 2.78–8.55) compared to
women in the lowest quintile, after adjusting for BMI, par-
ity, first-degree family history, hormone use, breast area,
and matching factors. The OR for each SD increment was
1.70 (95 % CI, 1.41–2.04). The association appeared to be
similar in analyses restricted to women aged 50+ years.
Odds ratios (ORs) for the association between DA and
breast cancer risk are shown in Table 3. Among all
women, those in the highest quintile of DA had a signifi-
cantly increased risk of breast cancer (OR, 3.48; 95 % CI,
2.14–5.65) compared to women in the lowest quintile,
after adjusting for BMI, parity, first-degree family his-
tory, hormone use, breast area, and matching factors. The
OR for each SD increment was 1.54 (95 % CI, 1.34–1.77).
The association was slightly stronger in analyses restricted
to women aged 50+ years.
Discussion
Studies of mammographic density as a risk factor or po-
tential surrogate of breast cancer risk have historically
used film-screen mammograms. Now that FFDM has
Table 1 Characteristics of 297 cases and 1149 controls
Cases Controls
N = 297 % N = 1149 %
Age at mammogram
Mean (SD) 63.79 7.21 63.95 7.00
Categories:
40–49 years 9 3.0 % 33 2.9 %
50–59 years 67 22.6 % 238 20.7 %
60–69 years 149 50.2 % 600 52.2 %
70+ years 72 24.2 % 278 24.2 %
Body mass index (kg/m2)
Mean (SD) 28.71 6.88 27.48 5.88
Categories:
24 or less 97 32.7 % 471 41.0 %
25–29 99 33.3 % 347 30.2 %
30–34 53 17.8 % 213 18.5 %
35–39 22 7.4 % 71 6.2 %
40+ 26 8.8 % 47 4.1 %
First-degree family history of breast cancer
No 257 86.5 % 1058 92.1 %
Yes 40 13.5 % 91 7.9 %
Use of postmenopausal hormonesa
None 237 79.8 % 939 81.7 %
Estrogen alone 28 9.4 % 106 9.2 %
Estrogen + progestin 32 10.8 % 104 9.1 %
Parity
Nulliparous 18 6.1 % 65 5.7 %
Parous 229 77.1 % 916 79.7 %
Missing 50 16.8 % 168 14.6 %
Percent densityb
Mean (SD) 22.00 13.81 19.51 14.77
Quintiles:
Q1: 6.08 or less 40 13.5 % 229 19.9 %
Q2: 6.09–11.94 49 16.5 % 230 20.0 %
Q3: 11.95–20.04 60 20.2 % 230 20.0 %
Q4: 20.05–31.56 69 23.2 % 230 20.0 %
Q5: 31.57+ 79 26.6 % 230 20.0 %
Area of densityb
Mean (SD) 32.66 20.13 26.33 17.47
Quintiles:
Q1: 11.95 or less 30 10.1 % 229 19.9 %
Q2: 11.96–19.09 45 15.2 % 230 20.0 %
Q3: 19.10–26.96 66 22.2 % 230 20.0 %
Q4: 26.97–37.78 68 22.9 % 230 20.0 %
Q5: 37.79+ 88 29.6 % 230 20.0 %
Total breast area
Mean (SD) 175.92 81.23 167.67 74.01
aWithin 2 years prior to mammogram date
bMeasures are untransformed. Quintiles calculated from distribution of controls
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replaced film-screen mammography as the most com-
mon breast imaging modality, it is critical to determine
whether density measured from digital images, especially
processed digital images routinely archived for clinical
care, are suitable for research purposes. Our study has
shown that breast density measured on processed digital
mammograms acquired from multiple Hologic units in
general practice settings is reproducible and strongly as-
sociated with risk of invasive breast cancer. The associa-
tions with breast cancer risk were slightly stronger for
PD than for DA, as has been found in studies using
film-screen mammograms [3]. Our findings indicate that
Table 2 Percent density, overall and for women age 50+ at mammogram
Quintile group Frequency Model 1a Model 2b Model 3c
Case Control OR 95 % CI OR 95 % CI OR 95 % CI
Percent density, overall (297 cases and 1149 controls)
Q1: 6.08 or less 40 229 1.00 Ref 1.00 Ref 1.00 Ref
Q2: 6.09–11.94 49 230 1.41 0.87–2.29 1.41 0.86–2.29 1.49 0.91–2.45
Q3: 11.95–20.04 60 230 2.37 1.44–3.89 2.38 1.44–3.91 2.57 1.54–4.30
Q4: 20.05–31.56 69 230 3.08 1.87–5.06 2.95 1.79–4.88 3.22 1.91–5.43
Q5: 31.57+ 79 230 4.45 2.62–7.56 4.36 2.55–7.43 4.88 2.78–8.55
Percent densityd 1.66 1.39–1.97 1.64 1.38–1.96 1.70 1.41–2.04
Percent density, women age 50+ (288 cases and 1116 controls)
Q1: 6.07 or less 40 223 1.00 Ref 1.00 Ref 1.00 Ref
Q2: 6.08–11.71 48 223 1.39 0.85–2.26 1.39 0.85–2.27 1.47 0.89–2.43
Q3: 11.72–19.71 57 223 2.23 1.35–3.68 2.24 1.36–3.71 2.43 1.45–4.08
Q4: 19.72-30.97 66 223 2.97 1.79–4.92 2.87 1.72–4.76 3.13 1.85–5.31
Q5: 30.98+ 77 224 4.22 2.49–7.16 4.16 2.45–7.08 4.65 2.66–8.14
Percent densityd 1.64 1.38–1.95 1.63 1.36–1.94 1.68 1.40–2.02
aAdjusted for matching factors (age at FFDM, laterality, density batch number), BMI (continuous), and BMI (categorical)
bAdjusted for matching factors, BMI (categorical and continuous), parity, first-degree family history, and hormone use
cAdjusted for matching factors, BMI (categorical and continuous), parity, first-degree family history, hormone use, and breast area (continuous)
dORs for square root of percent density (continuous) per standard deviation unit
Table 3 Area of density, overall and for women age 50+ at mammogram
Quintile group Frequency Model 1a Model 2b Model 3c
Case Control OR 95 % CI OR 95 % CI OR 95 % CI
Area of density, overall (297 cases and 1149 controls)
Q1: 11.95 or less 30 229 1.00 Ref 1.00 Ref 1.00 Ref
Q2: 11.96–19.09 45 230 1.44 0.86–2.42 1.45 0.86–2.43 1.43 0.85–2.40
Q3: 19.10–26.96 66 230 2.63 1.59–4.34 2.56 1.55–4.22 2.53 1.53–4.19
Q4: 26.97–37.78 68 230 2.86 1.74–4.69 2.88 1.75–4.75 2.85 1.73–4.69
Q5: 37.79+ 88 230 3.53 2.18–5.71 3.45 2.12–5.60 3.48 2.14–5.65
Dense aread 1.52 1.33–1.74 1.51 1.32–1.73 1.54 1.34–1.77
Area of density, women 50+ (288 cases and 1116 controls)
Q1: 11.80 or less 29 223 1.00 Ref 1.00 Ref 1.00 Ref
Q2: 11.81-18.71 44 223 1.48 0.88–2.51 1.49 0.88–2.52 1.47 0.87–2.50
Q3: 18.72-26.66 65 223 2.73 1.64–4.54 2.68 1.61–4.46 2.66 1.59–4.43
Q4: 26.67-37.40 66 223 2.96 1.79–4.91 2.96 1.79–4.92 2.93 1.76–4.87
Q5: 37.41+ 84 224 3.54 2.17–5.79 3.49 2.13–5.71 3.51 2.15–5.76
Dense aread 1.52 1.32–1.74 1.51 1.32–1.73 1.53 1.33–1.76
aAdjusted for matching factors (age at FFDM, laterality, density batch number), BMI (continuous), and BMI (categorical)
bAdjusted for matching factors, BMI (categorical and continuous), parity, first-degree family history, and hormone use
cAdjusted for matching factors, BMI (categorical and continuous), parity, first-degree family history, hormone use, and breast area (continuous)
dORs for cube root of dense area (continuous) per standard deviation unit
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processed Hologic FFDM images, which are widely used
for clinical care in the US, are suitable for determining
breast density for risk assessment and breast cancer
research.
The FDA approved the first clinical digital mammog-
raphy system for use in the US in early 2000 [4]. The
diagnostic accuracy is similar for film-screen and digital
mammography for all women combined. However,
digital mammography has been found to be better at de-
tecting breast cancers in women who are pre- or peri-
menopausal, under age 50 years, and have dense breasts
[11]. It is unknown why digital mammography performs
better for women with dense breasts, but one possible
explanation may be that proprietary imaging algorithms
enhance contrast between dense tissue and adjacent
structures [12]. Radiologists have observed that breasts
appear to be less dense on processed digital images than
on film mammograms [13]. Alterations of the appear-
ance of dense tissue on digital mammograms could ex-
plain differences in the association with breast cancer
risk compared to film mammograms or different FFDM
manufacturers.
To our knowledge, only one other study has examined
breast density measured using Hologic FFDM images in
relation to breast cancer risk. Fowler et al. [7] used both
Cumulus, as well as an automated method, to measure
PD from raw and processed images from 192 women
with breast cancer and 358 matched controls. The mean
PD was similar but slightly higher for processed than
raw images; mean PD for processed vs. raw was 18.1 vs.
15.0 for cases and 16.9 vs. 13.6 for controls. The re-
ported associations for Cumulus measures of PD were
similar for processed and raw FFDM images, but the
magnitude of the associations were weaker than in our
study. The adjusted OR reported for quartile 4 vs. 1 was
1.95 for processed and 2.04 for raw images. The adjusted
OR for a one SD increment of PD was 1.22 for processed
and 1.21 for raw images.
In an early study of FFDM images from General Electric
(GE) Senographe mammography machines (General
Electric Healthcare, Chicago, IL, USA), Nagata et al.
[14] used an automated density assessment method to
compare PD for 75 breast cancer cases and 289 con-
trols from Gifu City, Japan. Among postmenopausal
women, the mean PD was 18.2 for cases and 16.2 for
controls. The adjusted OR was 4.2 when comparing 50–
100 % dense to 0 % dense. More recently, Vachon et al. [6]
compared PD assessments from raw and processed FFDM
images from a single GE Senographe mammography ma-
chine. The study included 180 matched case-control pairs
and density was assessed by a single reader using the Cu-
mulus method. They found that intra-reader reproducibil-
ity was high for both raw and processed images (r = 0.92
and 0.87, respectively). Readings from raw and processed
images were strongly correlated (r = 0.82), and they had
similar means and standard deviations. For raw and proc-
essed images, respectively, the mean PD was 21.3 and 22.5
for cases, and 17.7 and 19.8 for controls. PD measured
from raw and processed GE digital images also showed
similar associations with breast cancer risk (the adjusted
OR for quartile 4 vs. 1 was 3.99 for processed and 5.17 for
raw images). In another recent study of FFDM images
from GE machines [15], Eng et al compared six density as-
sessment methods, including Cumulus. Prior to the Cu-
mulus assessments, the raw FFDM images (414 breast
cancer cases and 685 controls) were converted into film-
like images. The intra-reader reproducibility for PD was
0.90. Among controls, the median PD for Cumulus was
6.8. The adjusted OR comparing quintile 5 vs. 1 was 3.38,
and the adjusted OR for each SD increment of PD was
1.58. Thus, the associations with breast cancer risk, intra-
reader reproducibility, and PD distributions found in our
study of processed FFDM images were similar to previous
studies using GE images.
These initial results from density studies using FFDM
images are consistent with results from earlier studies
using film-screen mammograms. In a recent meta-
analysis of 13 case-control studies of mammographic
density and breast cancer risk using density measures
from film-screen mammograms, the summary OR for
each SD increment of PD was 1.52 for premenopausal
women and 1.53 for postmenopausal women [3]. The
meta-analysis finding of stronger associations with PD
than with DA is also similar to the pattern observed in
our study of processed Hologic mammograms.
Our study has several strengths. We included FFDMs
from multiple different mammography facilities ac-
quired over a 10-year period during 2003–2013, and
thus our results are likely to be generalizable to other
contemporary multi-institutional studies of Hologic
FFDM images. A single radiological technologist con-
ducted all assessments using the operator-assisted Cu-
mulus method, which is the most widely used density
measurement method for research studies. We exam-
ined both percent density and dense area and were
able to adjust for age, BMI, parity, first-degree family
history of breast cancer, and use of hormonal therapy
– all factors associated with both breast density and
breast cancer risk.
The study also had some limitations. All study partici-
pants are members of the Kaiser Permanente Northern
California health plan. While the membership is demo-
graphically quite similar to that of the general population
in northern California, it does slightly under-represent in-
dividuals at the extremes of the socioeconomic spectrum.
Nonetheless, members get virtually all their healthcare
from the plan, so all mammograms of interest were
available to the study.
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Conclusions
Our study is one of the first to demonstrate that density
assessments using Cumulus on processed Hologic FFDM
images for clinical display can be highly reproducible and
strongly associated with breast cancer risk. These findings
add to the growing evidence that FFDM images routinely
acquired and stored for clinical care in general practice
settings are an appropriate resource that can be leveraged
for large-scale research studies of breast density and
cancer risk. Our results suggest that the magnitude of
associations using FFDM images acquired from Hologic
machines, the most common type in the US, are similar to
those from GE machines and to film-screen mammog-
raphy [1, 2]. Further studies are needed to confirm
these findings. Given that FFDM hardware and software
vary by manufacturer and evolve over time, additional
studies using other FFDM systems, such as those man-
ufactured by Fuji Medical Imaging and Fischer Medical
Systems, are also needed. Further studies are also needed
to validate the emerging, fully automated methods to
measure density.
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